Candidate Biomarkers of Extravascular Extracellular Space: A Direct Comparison of Apparent Diffusion Coefficient and Dynamic Contrast-Enhanced MR Imaging—Derived Measurement of the Volume of the Extravascular Extracellular Space in Glioblastoma Multiforme

References

1. 1.↵
   1. Alexander DC,
   2. Hubbard PL,
   3. Hall MG,
   4. et al

   . Orientationally invariant axon-size and density weighted MRI. In: Proceedings of the International Society for Magnetic Resonance in Medicine, Honolulu, Hawaii. April 18-24, 2009
2. 2.↵
   1. Sen PN,
   2. Basser PJ

   . A model for diffusion in white matter in the brain. Biophys J 2005;89:2927–38

   CrossRefPubMedWeb of Science
3. 3.↵
   1. Tofts PS,
   2. Brix G,
   3. Buckley DL,
   4. et al

   . Estimating kinetic parameters from dynamic contrast-enhanced T1-weighted MRI of a diffusable tracer: standardized quantities and symbols. J Magn Reson Imaging 1999;10:223–32

   CrossRefPubMedWeb of Science
4. 4.↵
   1. Moffat BA,
   2. Chenevert TL,
   3. Lawrence TS,
   4. et al

   . Functional diffusion map: a noninvasive MRI biomarker for early stratification of clinical brain tumor response. Proc Natl Acad Sci U S A 2005;102:5524–29

   Abstract/FREE Full Text
5. 5.↵
   1. Chenevert TL,
   2. Stegman LD,
   3. Taylor JM,
   4. et al

   . Diffusion magnetic resonance imaging: an early surrogate marker of therapeutic efficacy in brain tumors. J Natl Cancer Inst 2000;92:2029–36

   Abstract/FREE Full Text
6. 6.↵
   1. Bastin ME,
   2. Carpenter TK,
   3. Armitage PA,
   4. et al

   . Effects of dexamethasone on cerebral perfusion and water diffusion in patients with high-grade glioma. AJNR Am J Neuroradiol 2006;27:402–08

   Abstract/FREE Full Text
7. 7.↵
   1. Bastin ME,
   2. Delgado M,
   3. Whittle IR,
   4. et al

   . The use of diffusion tensor imaging in quantifying the effect of dexamethasone on brain tumours. Neuroreport 1999;10:1385–91

   PubMed
8. 8.↵
   1. Sugahara T,
   2. Korogi Y,
   3. Kochi M,
   4. et al

   . Usefulness of diffusion-weighted MRI with echo-planar technique in the evaluation of cellularity in gliomas. J Magn Reson Imaging 1999;9:53–60

   CrossRefPubMedWeb of Science
9. 9.↵
   1. Kono K,
   2. Inoue Y,
   3. Nakayama K,
   4. et al

   . The role of diffusion-weighted imaging in patients with brain tumors. AJNR Am J Neuroradiol 2001;22:1081–88

   Abstract/FREE Full Text
10. 10.↵
    1. Guo AC,
    2. Cummings TJ,
    3. Dash RC,
    4. et al

    . Lymphomas and high-grade astrocytomas: comparison of water diffusibility and histologic characteristics. Radiology 2002;224:177–83

    CrossRefPubMedWeb of Science
11. 11.↵
    1. Yang D,
    2. Korogi Y,
    3. Sugahara T,
    4. et al

    . Cerebral gliomas: prospective comparison of multivoxel 2D chemical-shift imaging proton MR spectroscopy, echoplanar perfusion and diffusion-weighted MRI. Neuroradiology 2002;44:656–66

    CrossRefPubMed
12. 12.↵
    1. Yamasaki F,
    2. Kurisu K,
    3. Satoh K,
    4. et al

    . Apparent diffusion coefficient of human brain tumors at MR imaging. Radiology 2005;235:985–91

    CrossRefPubMedWeb of Science
13. 13.↵
    1. Lee EJ,
    2. Lee SK,
    3. Agid R,
    4. et al

    . Preoperative grading of presumptive low-grade astrocytomas on MR imaging: diagnostic value of minimum apparent diffusion coefficient. AJNR Am J Neuroradiol 2008;29:1872–77

    Abstract/FREE Full Text
14. 14.↵
    1. Ludemann L,
    2. Grieger W,
    3. Wurm R,
    4. et al

    . Quantitative measurement of leakage volume and permeability in gliomas, meningiomas and brain metastases with dynamic contrast-enhanced MRI. Magn Reson Imaging 2005;23:833–41

    CrossRefPubMed
15. 15.↵
    1. Zhu XP,
    2. Li KL,
    3. Kamaly-Asl ID,
    4. et al

    . Quantification of endothelial permeability, leakage space, and blood volume in brain tumors using combined T1 and T2* contrast-enhanced dynamic MR imaging. J Magn Reson Imaging 2000;11:575–85

    CrossRefPubMedWeb of Science
16. 16.↵
    1. Ludemann L,
    2. Grieger W,
    3. Wurm R,
    4. et al

    . Comparison of dynamic contrast-enhanced MRI with WHO tumor grading for gliomas. Eur Radiol 2001;11:1231–41

    CrossRefPubMed
17. 17.↵
    1. Andersen C,
    2. Jensen FT

    . Differences in blood-tumour-barrier leakage of human intracranial tumours: quantitative monitoring of vasogenic oedema and its response to glucocorticoid treatment. Acta Neurochir (Wien) 1998;140:919–24

    CrossRefPubMed
18. 18.↵
    1. Armitage PA,
    2. Schwindack C,
    3. Bastin ME,
    4. et al

    . Quantitative assessment of intracranial tumor response to dexamethasone using diffusion, perfusion and permeability magnetic resonance imaging. Magn Reson Imaging 2007;25:303–10

    CrossRefPubMedWeb of Science
19. 19.↵
    1. McMillan KM,
    2. Rogers BP,
    3. Koay CG,
    4. et al

    . An objective method for combining multi-parametric MRI datasets to characterize malignant tumors. Med Phys 2007;34:1053–61

    CrossRefPubMed
20. 20.↵
    1. Fram EK,
    2. Herfkens RJ,
    3. Johnson GA,
    4. et al

    . Rapid calculation of T1 using variable flip angle gradient refocused imaging. Magn Reson Imaging 1987;5:201–08

    CrossRefPubMedWeb of Science
21. 21.↵
    1. Tofts PS

    . Modeling tracer kinetics in dynamic Gd-DTPA MR imaging. J Magn Reson Imaging 1997;7:91–101

    CrossRefPubMedWeb of Science
22. 22.↵
    1. Parker GJ,
    2. Jackson A,
    3. Waterton JC,
    4. et al

    . Automated arterial input function extraction for T1-weighted DCE-MRI. In: Proceedings of the 11th Annual Meeting of International Society for Magnetic Resonance in Medicine, Toronto, Ontario, Canada. July 10–16, 2003:Abstract No. 1264
23. 23.↵
    1. Jiang H,
    2. van Zijl PC,
    3. Kim J,
    4. et al

    . DTIStudio: resource program for diffusion tensor computation and fiber bundle tracking. Comput Methods Programs Biomed 2006;81:106–16

    CrossRefPubMedWeb of Science
24. 24.↵
    1. Jenkinson M,
    2. Smith S

    . A global optimisation method for robust affine registration of brain images. Med Image Anal 2001;5:143–56

    CrossRefPubMedWeb of Science
25. 25.↵
    1. Yankeelov TE,
    2. Lepage M,
    3. Chakravarthy A,
    4. et al

    . Integration of quantitative DCE-MRI and ADC mapping to monitor treatment response in human breast cancer: initial results. Magn Reson Imaging 2007;25:1–13

    CrossRefPubMedWeb of Science
26. 26.↵
    1. Guo Y,
    2. Cai YQ,
    3. Cai ZL,
    4. et al

    . Differentiation of clinically benign and malignant breast lesions using diffusion-weighted imaging. J Magn Reson Imaging 2002;16:172–78

    CrossRefPubMedWeb of Science
27. 27.↵
    1. Kinoshita T,
    2. Yashiro N,
    3. Ihara N,
    4. et al

    . Diffusion-weighted half-Fourier single-shot turbo spin echo imaging in breast tumors: differentiation of invasive ductal carcinoma from fibroadenoma. J Comput Assist Tomogr 2002;26:1042–46

    CrossRefPubMed
28. 28.↵
    1. Kuroki Y,
    2. Nasu K,
    3. Kuroki S,
    4. et al

    . Diffusion-weighted imaging of breast cancer with the sensitivity encoding technique: analysis of the apparent diffusion coefficient value. Magn Reson Med Sci 2004;3:79–85

    CrossRefPubMed
29. 29.↵
    1. Sinha S,
    2. Lucas-Quesada FA,
    3. Sinha U,
    4. et al

    . In vivo diffusion-weighted MRI of the breast: potential for lesion characterization. J Magn Reson Imaging 2002;15:693–704

    CrossRefPubMedWeb of Science
30. 30.↵
    1. Woodhams R,
    2. Matsunaga K,
    3. Iwabuchi K,
    4. et al

    . Diffusion-weighted imaging of malignant breast tumors: the usefulness of apparent diffusion coefficient (ADC) value and ADC map for the detection of malignant breast tumors and evaluation of cancer extension. J Comput Assist Tomogr 2005;29:644–49

    CrossRefPubMed
31. 31.↵
    1. Woodhams R,
    2. Matsunaga K,
    3. Kan S,
    4. et al

    . ADC mapping of benign and malignant breast tumors. Magn Reson Med Sci 2005;4:35–42

    CrossRefPubMed
32. 32.↵
    1. Norris DG

    . The effects of microscopic tissue parameters on the diffusion weighted magnetic resonance imaging experiment. NMR Biomed 2001;14:77–93

    CrossRefPubMedWeb of Science
33. 33.↵
    1. Le Bihan D,
    2. Breton E,
    3. Lallemand D,
    4. et al

    . MR imaging of intravoxel incoherent motions: application to diffusion and perfusion in neurologic disorders. Radiology 1986;161:401–07

    CrossRefPubMedWeb of Science
34. 34.↵
    1. Brunberg JA,
    2. Chenevert TL,
    3. McKeever PE,
    4. et al

    . In vivo MR determination of water diffusion coefficients and diffusion anisotropy: correlation with structural alteration in gliomas of the cerebral hemispheres. AJNR Am J Neuroradiol 1995;16:361–71

    Abstract/FREE Full Text
35. 35.↵
    1. Sadeghi N,
    2. D'Haene N,
    3. Decaestecker C,
    4. et al

    . Apparent diffusion coefficient and cerebral blood volume in brain gliomas: relation to tumor cell density and tumor microvessel density based on stereotactic biopsies. AJNR Am J Neuroradiol 2008;29:476–82

    Abstract/FREE Full Text
36. 36.↵
    1. Shellock FG,
    2. Spinazzi A

    . MRI safety update 2008. Part 1. MRI contrast agents and nephrogenic systemic fibrosis. AJR Am J Roentgenol 2008;191:1129–39

    CrossRefPubMedWeb of Science
37. 37.↵
    1. Bellin MF,
    2. Van Der Molen AJ

    . Extracellular gadolinium-based contrast media: an overview. Eur J Radiol 2008;66:160–67

    CrossRefPubMed
38. 38.↵
    1. van der Molen AJ,
    2. Bellin MF

    . Extracellular gadolinium-based contrast media: differences in diagnostic efficacy. Eur J Radiol 2008;66:168–74

    CrossRefPubMed